Your browser doesn't support javascript.
loading
Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.
Bödör, Csaba; Kotmayer, Lili; László, Tamás; Takács, Ferenc; Barna, Gábor; Kiss, Richárd; Sebestyén, Endre; Nagy, Tibor; Hegyi, Lajos László; Mikala, Gábor; Fekete, Sándor; Farkas, Péter; Balogh, Alexandra; Masszi, Tamás; Demeter, Judit; Weisinger, Júlia; Alizadeh, Hussain; Kajtár, Béla; Kohl, Zoltán; Szász, Róbert; Gergely, Lajos; Gurbity Pálfi, Timea; Sulák, Adrienn; Kollár, Balázs; Egyed, Miklós; Plander, Márk; Rejto, László; Szerafin, László; Ilonczai, Péter; Tamáska, Péter; Pettendi, Piroska; Lévai, Dóra; Schneider, Tamás; Sebestyén, Anna; Csermely, Péter; Matolcsy, András; Mátrai, Zoltán; Alpár, Donát.
Afiliação
  • Bödör C; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Kotmayer L; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • László T; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Takács F; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Barna G; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Kiss R; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Sebestyén E; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Nagy T; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Hegyi LL; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Mikala G; South-Pest Central Hospital-National Institute of Hematology and Infectology, Budapest, Hungary.
  • Fekete S; South-Pest Central Hospital-National Institute of Hematology and Infectology, Budapest, Hungary.
  • Farkas P; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Balogh A; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Masszi T; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Demeter J; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Weisinger J; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Alizadeh H; 1st Department of Internal Medicine, Clinical Centre, University of Pécs, Pécs, Hungary.
  • Kajtár B; Department of Pathology, University of Pécs Medical School, Pécs, Hungary.
  • Kohl Z; 1st Department of Internal Medicine, Clinical Centre, University of Pécs, Pécs, Hungary.
  • Szász R; Division of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
  • Gergely L; Division of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
  • Gurbity Pálfi T; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Sulák A; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Kollár B; Kaposi Mór University Teaching Hospital of County Somogy, Kaposvár, Hungary.
  • Egyed M; Kaposi Mór University Teaching Hospital of County Somogy, Kaposvár, Hungary.
  • Plander M; Markusovszky University Teaching Hospital, Szombathely, Hungary.
  • Rejto L; Hospitals of County Szabolcs-Szatmár-Bereg and University Teaching Hospital, Nyíregyháza, Hungary.
  • Szerafin L; Hospitals of County Szabolcs-Szatmár-Bereg and University Teaching Hospital, Nyíregyháza, Hungary.
  • Ilonczai P; Hospitals of County Szabolcs-Szatmár-Bereg and University Teaching Hospital, Nyíregyháza, Hungary.
  • Tamáska P; Markhot Ferenc Teaching Hospital of County Heves, Eger, Hungary.
  • Pettendi P; Borsod-Abaúj-Zemplén County Hospital and University Teaching Hospital, Miskolc, Hungary.
  • Lévai D; Hetényi Géza Hospital and Clinic of County Jász-Nagykun-Szolnok, Szolnok, Hungary.
  • Schneider T; National Institute of Oncology, Budapest, Hungary.
  • Sebestyén A; National Institute of Oncology, Budapest, Hungary.
  • Csermely P; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Matolcsy A; Department of Molecular Biology, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary.
  • Mátrai Z; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Alpár D; Department of Laboratory Medicine, Karolinska Institute, Solna, Sweden.
Br J Haematol ; 194(2): 355-364, 2021 07.
Article em En | MEDLINE | ID: mdl-34019713
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article